Global BulletinAll NewsFDA Approval AlertWomen in Oncology
Expert InterviewsAround the PracticeBetween the LinesFace OffFrom All AnglesMeeting of the MindsOncViewPodcastsTraining AcademyTreatment Algorithms with the Oncology Brothers
Conferences
All JournalsEditorial BoardFor AuthorsYear in Review
Frontline ForumSatellite Sessions
CME/CE
Awareness MonthInteractive ToolsNurse Practitioners/Physician's AssistantsPartnersSponsoredSponsored Media
Career CenterSubscribe
Adverse Effects
Brain Cancer
Breast CancerBreast CancerBreast Cancer
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
Head & Neck Cancer
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
InfectionInfection
Leukemia
Lung CancerLung CancerLung Cancer
Lymphoma
Neuroendocrine Tumors
Oncology
Pediatric Cancers
Radiation Oncology
Sarcoma
Screening
Skin Cancer & Melanoma
Surgery
Thyroid Cancer
Spotlight -
  • Radiation Oncology
  • Surgery
Adverse Effects
Brain Cancer
Breast CancerBreast CancerBreast Cancer
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
Head & Neck Cancer
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
InfectionInfection
Leukemia
Lung CancerLung CancerLung Cancer
Lymphoma
Neuroendocrine Tumors
Oncology
Pediatric Cancers
Radiation Oncology
Sarcoma
Screening
Skin Cancer & Melanoma
Surgery
Thyroid Cancer
    • Conferences
    • CME/CE
    • Career Center
    • Subscribe
Advertisement

ONCOLOGY® Companion, Volume 38, Supplement 9

home / journals / oncology-companion / oncology-companion-volume-38-supplement-9
Advertisement

Neoadjuvant Therapy Trumps Surgery in NSCLC Debate

Neoadjuvant Therapy Trumps Surgery in NSCLC Debate

ONCOLOGY Staff
September 30th 2024
Article

The University of Chicago goes against Northwestern Medicine to see who will be crowned the winner in the NSCLC debate.


Dato-DXd: A Path to Potential Approval in NSCLC

Dato-DXd: A Path to Potential Approval in NSCLC

ONCOLOGY Staff
September 29th 2024
Article

Experts discussed the advancements in non–small cell lung cancer treatment and developments in both antibody-drug conjugate–based approaches and targeted therapies.


Optimizing AE Management Post CAR T-Cell Therapy in Multiple Myeloma

Optimizing AE Management Post CAR T-Cell Therapy in Multiple Myeloma

ONCOLOGY Staff
September 28th 2024
Article

Experts spoke about the best practices for mitigating adverse effects associated with CAR T-cell therapy in relapsed/refractory multiple myeloma.


Long-Term Data Affirm Enduring Responses With Teclistamab in R/R Multiple Myeloma

Long-Term Data Affirm Enduring Responses With Teclistamab in R/R Multiple Myeloma

ONCOLOGY Staff
September 22nd 2024
Article

Amrita Y. Krishnan, MD, and Binod Dhakal, MD, gave a high-level overview of teclistamab use in the MajesTEC-1 trial.


Exploring GPRC5D as an Important Target for Multiple Myeloma

Exploring GPRC5D as an Important Target for Multiple Myeloma

ONCOLOGY Staff
September 21st 2024
Article

Experts highlighted the use of GPRC5D therapy in patients with multiple myeloma.

Advertisement
About
Advertise
CureToday.com
OncLive.com
OncNursingNews.com
TargetedOnc.com
Editorial
Contact
Terms and Conditions
Privacy
Do Not Sell My Personal Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.